Total Funding
32
55
Total FundingSeed raised
Growth Score 32 in past quarter
27 pts
Heat Score 55 in past quarter
9 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
143476
LSK Technologies is a company that provides a low cost and an effective diagnostic device that tests Covid19 and other hundreds of diseases.
- Yuxiu Livia Guo: Co-Founder & COO
- Seray Cicek: Co-Founder & CEO

Nicoya Lifesciences
About the Company
LSK is looking to tap computer vision to build disease testing hardware (a “lab in a box,” as they put it) small/fast enough to keep in a doctor’s office or workplace. The company says it’s currently running the Zika Virus field trials in Latin America and is looking at how they can bring their computer vision approach in to help tackle the
COVID-19 pandemic. They also say they’ve seen over $100,000 in pre-orders to date.